Martin J. Taphoorn

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 214 publications

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 02, 2026

Prognostic value for overall survival of the EORTC QLQ-C30 Summary Score: An analysis of 5 closed EORTC trials.

Prognostic value for overall survival of the EORTC QLQ-C30 Summary Score: An analysis of 5 closed EORTC trials.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 11, 2026

End-of-life care in patients with glioblastoma after early advance care planning.

End-of-life care in patients with glioblastoma after early advance care planning.

Journal: Neuro-oncology practice

Published: October 13, 2025

Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysis.

Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysis.

Journal: The oncologist

Published: September 11, 2025

Core Outcome Sets for Meningioma In Clinical studies (COSMIC): An international patient and healthcare professional consensus for research studies.

Core Outcome Sets for Meningioma In Clinical studies (COSMIC): An international patient and healthcare professional consensus for research studies.

Journal: Neuro-oncology practice

Published: August 15, 2025

Early Palliative Care in Patients with Glioblastoma: Co-Design of an Integrated Care Pathway.

Early Palliative Care in Patients with Glioblastoma: Co-Design of an Integrated Care Pathway.

Journal: Healthcare (Basel, Switzerland)

Published: August 13, 2025

The use of EORTC QLQ-C30 Summary Score in cancer research and its performance as compared with the EORTC QLQ-C30 Global Health/Quality of Life scale: A systematic review and comparative analysis of effect sizes.

The use of EORTC QLQ-C30 Summary Score in cancer research and its performance as compared with the EORTC QLQ-C30 Global Health/Quality of Life scale: A systematic review and comparative analysis of effect sizes.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 01, 2025

Challenges in interpreting individual-level changes in health-related quality of life in patients with glioma using minimally important differences (MIDs) and a 4-point Likert scale.

Challenges in interpreting individual-level changes in health-related quality of life in patients with glioma using minimally important differences (MIDs) and a 4-point Likert scale.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: July 10, 2025

Seizure outcomes in patients with brain metastases and epilepsy: a systematic review on the efficacy of antitumor treatment and antiseizure medication.

Seizure outcomes in patients with brain metastases and epilepsy: a systematic review on the efficacy of antitumor treatment and antiseizure medication.

Journal: Neuro-oncology practice

Published: June 09, 2025

Surgery for pineal cysts with symptoms in the absence of hydrocephalus: a prospective cohort study.

Surgery for pineal cysts with symptoms in the absence of hydrocephalus: a prospective cohort study.

Journal: EClinicalMedicine

Published: May 17, 2025

Long-Term Follow-Up Results of Antiseizure Medication Withdrawal in Grade 2 and 3 Glioma Patients: A Prospective Observational Study.

Long-Term Follow-Up Results of Antiseizure Medication Withdrawal in Grade 2 and 3 Glioma Patients: A Prospective Observational Study.

Journal: Neurology

Published: April 29, 2025

Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative.

Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative.

Journal: Neuro-oncology

Published: April 28, 2025

Showing 1-12 of 214

Last Updated: 09/26/2026